E. E. Kondyurov
E. E. Kondyurov has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Inna N. Lebedeva
Ryazan Regional Child Hospital
1 shared publication - Natalia Anatolyevna Belykh
Federal State Budgetary Educational Institution of Higher Education “Ryazan State Medical University named after Academician I. P. Pavlov” of the Ministry of Health of the Russian Federation
1 shared publication - Yu. V. Deeva
Ryazan State Medical University
1 shared publication
Latest Publications
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
МicroRNA as promising biomarkers of obesity comorbidities in childhood
The growing number of obese children creates the need to find modern indicators for the early detection of concomitant diseases. Candidates for the role of biomarkers may be microRNAs that naturally suppress gene expression. Objective. To present and summarize information about the features of microRNA expression in children with obesity and comorbid pathology. Materials and methods. The results of studies on the assessment of microRNA expression in childhood obesity complications were searched using Scopus, Web of Science, PubMed, Google Scholar, eLibrary, and Cyberleninka databases. Results. Studies on endothelial dysfunction in childhood obesity have identified microRNAs-320a and -630 as possible indicators of diagnosis and treatment. The search for alternative markers for the diagnosis of metabolic dysfunction-associated steatotic liver disease has revealed the value of several signaling molecules (microRNAs-199a-5p, -22, -122, -486, -146b and -15b), which can also be used to assess the risk of type 2 mellitus, metabolic syndrome and insulin resistance in children. No significant relationship has been established between the studied microRNAs and atherosclerosis. Conclusion. MicroRNAs are promising prognostic markers for the early detection of endothelial dysfunction, metabolic associated steatotic liver disease, type 2 diabetes, metabolic syndrome, and insulin resistance in obese children.
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
МicroRNA as promising biomarkers of obesity comorbidities in childhood
The growing number of obese children creates the need to find modern indicators for the early detection of concomitant diseases. Candidates for the role of biomarkers may be microRNAs that naturally suppress gene expression. Objective. To present and summarize information about the features of microRNA expression in children with obesity and comorbid pathology. Materials and methods. The results of studies on the assessment of microRNA expression in childhood obesity complications were searched using Scopus, Web of Science, PubMed, Google Scholar, eLibrary, and Cyberleninka databases. Results. Studies on endothelial dysfunction in childhood obesity have identified microRNAs-320a and -630 as possible indicators of diagnosis and treatment. The search for alternative markers for the diagnosis of metabolic dysfunction-associated steatotic liver disease has revealed the value of several signaling molecules (microRNAs-199a-5p, -22, -122, -486, -146b and -15b), which can also be used to assess the risk of type 2 mellitus, metabolic syndrome and insulin resistance in children. No significant relationship has been established between the studied microRNAs and atherosclerosis. Conclusion. MicroRNAs are promising prognostic markers for the early detection of endothelial dysfunction, metabolic associated steatotic liver disease, type 2 diabetes, metabolic syndrome, and insulin resistance in obese children.